Kyle Dempsey
Director/Miembro de la Junta en OPTINOSE, INC. .
Fortuna: 6 089 $ al 30/04/2024
Perfil
Kyle Dempsey currently works at OptiNose, Inc., as Independent Director from 2021, GT Medical Technologies, Inc., as Director, HLS Therapeutics, Inc., as Independent Director from 2022, and MVM Partners LLC, as Partner from 2017.
Dr. Dempsey received his undergraduate degree from Bowdoin College, doctorate degree from Harvard Medical School, and Masters Business Admin degree from Harvard Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HLS THERAPEUTICS, INC.
0.01% | 31/03/2024 | 1 765 ( 0.01% ) | 6 089 $ | 30/04/2024 |
OPTINOSE, INC.
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Kyle Dempsey
| Empresas | Cargo | Inicio |
|---|---|---|
| OPTINOSE, INC. | Director/Miembro de la Junta | 10/12/2021 |
| HLS THERAPEUTICS INC. | Director/Miembro de la Junta | 29/11/2022 |
| MVM Partners LLC | Inversor de Capital Privado | 01/09/2017 |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Director/Miembro de la Junta | - |
Formación de Kyle Dempsey.
| Harvard Medical School | Doctorate Degree |
| Bowdoin College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| MVM Partners LLC | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Health Technology |
- Bolsa de valores
- Insiders
- Kyle Dempsey